✦ LIBER ✦

Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisone

✍ Scribed by Philip, PA; Carmichael, J; Tonkin, K; Buamah, PK; Britton, J; Dowsett, M; Harris, AL

Book ID: 109836955
Publisher: Nature Publishing Group
Year: 1993
Tongue: English
Weight: 850 KB
Volume: 67
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1993.69

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LHRH agonist treatment of breast cancer:

LHRH agonist treatment of breast cancer: A phase II study in the U.S.A.

✍ van Hogezand, Ruud A.; Russel, Maurice G.; Naber, Anton; Oldenburg, Bas; Bodegra 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 149 KB

Fixed higher dose schedule of suramin pl

Fixed higher dose schedule of suramin plus hydrocortisone in patients with hormone refractory prostate carcinoma : A multicenter Phase II study

✍ Emiliano Calvo; Javier Cortés; Javier Rodríguez; Manuel Sureda; César Beltrán; J 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

Mitomycin C treatment of advanced, hormo

Mitomycin C treatment of advanced, hormone-resistant prostatic carcinoma: a phase II study

✍ A. Veronesi; V. Dal Bo; G. Lo Re; M. Della Valentina; U. Tirelli; A. Merlo; R. T 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 174 KB

Phase II study of gemcitabine and cispla

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma

✍ Philip A. Philip; Mark M. Zalupski; V. K. Vaitkevicius; Patricia Arlauskas; Ruth 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

External Beam Radiotherapy Plus 24-Hour

External Beam Radiotherapy Plus 24-Hour Continuous Infusion of Gemcitabine in Unresectable Pancreatic Carcinoma: Long-Term Results of a Phase II Study

✍ Gian C. Mattiucci; Alessio G. Morganti; Vincenzo Valentini; Edy Ippolito; Sergio 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 309 KB

A phase II study of hypofractionated rad

A phase II study of hypofractionated radiotherapy in combination with Gemcitabin in the palliative treatment of advanced pancreatic carcinoma

✍ I.E. Antonisse; C.J. van Groeningen; J.A. Langendijk; B.J. Slotman 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 166 KB